Mark McGee

846 total citations
7 papers, 691 citations indexed

About

Mark McGee is a scholar working on Psychiatry and Mental health, Epidemiology and Pharmacology. According to data from OpenAlex, Mark McGee has authored 7 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 2 papers in Epidemiology and 1 paper in Pharmacology. Recurrent topics in Mark McGee's work include Schizophrenia research and treatment (6 papers), Substance Abuse Treatment and Outcomes (2 papers) and Bipolar Disorder and Treatment (2 papers). Mark McGee is often cited by papers focused on Schizophrenia research and treatment (6 papers), Substance Abuse Treatment and Outcomes (2 papers) and Bipolar Disorder and Treatment (2 papers). Mark McGee collaborates with scholars based in United States and United Kingdom. Mark McGee's co-authors include Joseph P. McEvoy, T. Scott Stroup, Jeffrey A. Lieberman, Marvin S. Swartz, Fred Reimherr, Oliver Freudenreich, Edward D. Levin, Jed E. Rose, Robert A. Rosenheck and Sonia M. Davis and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and The Journal of Nervous and Mental Disease.

In The Last Decade

Mark McGee

7 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark McGee United States	6	476	147	128	112	111	7	691
Anna Mané Spain	18	583 1.2×	149 1.0×	89 0.7×	56 0.5×	106 1.0×	70	902
Jürgen Minges Germany	20	396 0.8×	276 1.9×	155 1.2×	130 1.2×	56 0.5×	27	849
N. Ciani Italy	13	320 0.7×	138 0.9×	113 0.9×	54 0.5×	65 0.6×	34	583
Michal Kunz United States	12	740 1.6×	301 2.0×	165 1.3×	108 1.0×	115 1.0×	17	1.1k
Scott W Woods United States	11	536 1.1×	224 1.5×	153 1.2×	79 0.7×	241 2.2×	17	964
R. W. Buchanan United States	8	690 1.4×	170 1.2×	89 0.7×	77 0.7×	271 2.4×	8	853
Evelyn Howanitz United States	8	465 1.0×	90 0.6×	97 0.8×	84 0.8×	148 1.3×	12	612
Nikos C. Stefanis Greece	13	258 0.5×	135 0.9×	54 0.4×	48 0.4×	45 0.4×	48	609
Ashok Malla Canada	8	436 0.9×	161 1.1×	43 0.3×	31 0.3×	133 1.2×	16	562
Torben Mackeprang Denmark	11	427 0.9×	212 1.4×	160 1.3×	73 0.7×	62 0.6×	18	721

Countries citing papers authored by Mark McGee

Since Specialization

Citations

This map shows the geographic impact of Mark McGee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark McGee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark McGee more than expected).

Fields of papers citing papers by Mark McGee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark McGee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark McGee. The network helps show where Mark McGee may publish in the future.

Co-authorship network of co-authors of Mark McGee

This figure shows the co-authorship network connecting the top 25 collaborators of Mark McGee. A scholar is included among the top collaborators of Mark McGee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark McGee. Mark McGee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Swartz, Marvin S., Henry R. Wagner, Jeffrey W. Swanson, et al.. (2008). The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: Results from the CATIE study. Schizophrenia Research. 100(1-3). 39–52. 53 indexed citations

2.

Swartz, Marvin S., Diana O. Perkins, T. Scott Stroup, et al.. (2007). Effects of Antipsychotic Medications on Psychosocial Functioning in Patients With Chronic Schizophrenia: Findings From the NIMH CATIE Study. American Journal of Psychiatry. 164(3). 428–436. 222 indexed citations

3.

Swartz, Marvin S., Henry R. Wagner, Jeffrey W. Swanson, et al.. (2006). Substance Use in Persons With Schizophrenia. The Journal of Nervous and Mental Disease. 194(3). 164–172. 118 indexed citations

4.

Swartz, Marvin S., Henry R. Wagner, Jeffrey W. Swanson, et al.. (2006). Substance Use and Psychosocial Functioning in Schizophrenia Among New Enrollees in the NIMH CATIE Study. Psychiatric Services. 57(8). 1110–1116. 55 indexed citations

5.

Wynn, Jonathan K., et al.. (2004). Prepulse facilitation and prepulse inhibition in schizophrenia patients and their unaffected siblings. Biological Psychiatry. 55(5). 518–523. 77 indexed citations

6.

McEvoy, Joseph P., et al.. (1996). A double-blind, randomized trial comparing clozapine treatment within three distinct serum level ranges in patients with refractory chronic schizophrenia. Schizophrenia Research. 18(2-3). 127–127. 3 indexed citations

7.

McEvoy, Joseph P., et al.. (1995). Clozapine decreases smoking in patients with chronic schizophrenia. Biological Psychiatry. 37(8). 550–552. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact